Search Results - "Roumen, F.J.M.E"

Gestational Hypertension or Preeclampsia at Term (HYPITAT Trial) by Vijgen, S.M.C, Koopmans, C.M, Opmeer, B.C, Groen, H, Bijlenga, D, Aarnoudse, J.G, Bekedam, D.J, van den Berg, P.P, de Boer, K, Burggraaff, J.M, Bloemenkamp, K.W.M, Drogtrop, A.P, Franx, A, de Groot, C.J.M, Huisjes, A.J.M, Kwee, A, van Loon, A.J, Lub, A, Papatsonis, D.N.M, van der Post, J.A.M, Roumen, F.J.M.E, Scheepers, H.C.J, Stigter, R.H, Willekes, C, Mol, B.W.J, Van Pampus, M.G

“…(BJOG. 2010;117(13):1577–85)…”
Get full text

Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol by Roumen, F.J.M.E., Apter, D., Mulders, T.M.T., Dieben, T.O.M.

“…A novel contraceptive vaginal ring releasing etonogestrel 120 μg and ethinyl oestradiol 15 μg daily over a period of 3 weeks was tested. Each ring was used for…”
Get full text

Reply by Molkenboer, J.F.M., Roumen, F.J.M.E., Nijhuis, J.G., Smits, L.J.M.

Get full text

Birth weight and neurodevelopmental outcome of children at 2 years of age after planned vaginal delivery for breech presentation at term by Molkenboer, J.F.M., Roumen, F.J.M.E., Smits, L.J.M., Nijhuis, J.G.

“…The purpose of this prospective cohort study was to determine whether planned vaginal delivery for the term singleton baby in breech position increases the…”
Get full text

Reply by Molkenboer, J.F.M., MD, Roumen, F.J.M.E., MD, PhD, Nijhuis, J.G., MD, PhD, Smits, L.J.M., PhD

Get full text

Fertility control. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol by F.J.M.E. Roumen, Apter, D, T.M.T. Mulders, T.O.M. Dieben

“…A novel contraceptive vaginal ring releasing etonogestrel 120 [mu]g and ethinyl oestradiol 15 [mu]g daily over a period of 3 weeks was tested. Each ring was…”
Get full text

Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring by Roumen, F.J.M.E, Dieben, T.O.M

“…In an open study the acceptability of a newly designed vaginal ring was evaluated. The ring being developed for contraceptive purposes was made of…”
Get full text

Contraception: The cervico—vaginal epithelium during 20 cycles' use of a combined contraceptive vaginal ring by Roumen, F.J.M.E., Boon, M.E., van Velzen, D., Dieben, T.O.M., Bennink, H.J.T.Coelingh

“…The aim of the study was to evaluate the influence of a combined contraceptive vaginal ring (CCVR) made of Silastic® on the cervico-vaginal epithelium during…”
Get full text